Market Competition Linked to Change in Generic Drug Prices
Price change of −31.7 percent for quadropoly and 47.4 percent for monopoly
June 2017 Briefing – Nephrology
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for June 2017. This roundup includes the latest...
Poll Finds Seniors Struggling With Drug Costs Don’t Seek Help
Roughly half of older Americans don't, but those who do receive assistance from their doctor
Tryptophan May Be Marker for Diabetic Nephropathy
Lower level of tryptophan, especially below 44.20 µM related to rapid decline in eGFR
Doctors Urged to Take Care With Electronic Communications
Sensitive information should be discussed in person or over the phone
Health of the Nation Presented in 40th Annual CDC Report
Report includes trends of data for past 40 years, with increase in life expectancy, drop in infant mortality
FDA Seeks to Increase Number of Generic Drugs on Market
Agency will now give priority reviews to new generic drugs until there are at least three available
suPAR Protein Levels Impact CKD Risk With APOL1 Variants
Risk reduced with lower levels of plasma suPAR, strengthened by higher levels
Rate of Hip Fracture Declining in End-Stage Renal Disease
From 2003 to 2011 there was a decrease in hip fracture rate, in-hospital mortality after hip fracture
sRAGE Linked to Risk of Incident Diabetic Nephropathy
Independent link seen for soluble receptor for advanced glycation end products, but not for CML
